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Abstract
Purpose The medical morbidity and mortality associated with neck of femur fractures is well-documented, whereas there is
limited data for patient-reported outcomes. The aim of this study was to characterize the impact of neck of femur fractures on
activities of daily living and patient-reported health-related quality of life.
Methods Design and participants: Multicentric prospective cohort study. Consecutive sample patients with fragility hip fracture
over 50 years old admitted in 48 hospitals in Spain.
Outcomes: daily living activity function (Barthel Index) and health-related quality of life (EQ-5D) pre-fracture, admission to
hospital and at 1- and 4-month follow-up post-fracture.
Statistics: Barthel and EQ-5D over time are described as mean (SD) and median (interquartile range).
Results A total of 997 patients were recruited at baseline with 4-month outcomes available for, and 856 patients (89.5%). Barthel
Index fell from 78.77 (23.75) at baseline to 43.62 (19.86) on admission to hospital with the fracture. Scores partially recovered to
54.89 (25.40) and 64.09 (21.35) at 1- and 4-month post-fracture, respectively. EQ-5D fell from amedian of 0.75 (0.47–0.91) to −
0.01 (− 0.03 to 0.51) on admission. Partial recovery was observed again to (0.51 (− 0.06 to 0.67)) and (0.60 (0.10 to 0.80)) at 1-
and 4-month post-fracture, respectively.
Conclusions Hip fracture results in a large decline in the ability to perform activities of daily living and patient-reported health-
related quality of life with only partial recovery amongst survivors 4-month post-fracture.
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Introduction
A total of 620,000 hip fractures were sustained in the
European Union in 2010.Osteoporotic hip fractures are asso-
ciated with significant morbidity, mortality and societal costs
[1]. Fragility fractures of any site had an estimated economic
burden of € 37 billion and accounted for almost 1.2 million
quality-adjusted life years in that same year [2].
It is estimated that between 2020 and 2050, the number of hip
fractures worldwidewill increase tomore than 2 billion cases [3].
This will represent a large socioeconomic burden [4, 5].
Despite the increasing socioeconomic burden, there is a
scarcity of data on the impact of hip fracture to patients in
terms of patient-reported outcomes and activities of daily liv-
ing. Particularly, there is no previous reports to our knowledge
of both in a same cohort in Spain. This is important for a
comprehensive assessment of the burden of hip fractures in
the Spanish population.
The aim of this study is to determine the association be-
tween proximal femur fragility fractures and patient-reported
health-related quality of life and activities of daily living dur-
ing the 4-month following fracture.
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Methods
Study design and setting
Multi-centre prospective observational cohort study in 48 hos-
pitals in Spain
Eligibility criteria
Details on sampling strategies, data collection and follow-up
have been reported elsewhere [6]. One thousand consecutive
men or women aged ≥ 50 years old with a diagnosis of a
fragility femur fracture were recruited. Consent was obtained
from patient or principal carer and/or legal representative of
the patient.
Measurements
Data was collected during consultations on admission and at
1-month and 4-month follow-up appointments. Phone consul-
tations were conducted for the 1 month and 4 months when
face-to-face visits were not possible. Baseline (pre-fracture)
measures were collected on admission to hospital-based on
patient recollection of their previous activity and health status.
Outcome measures were Barthel Index (ability to perform
activities of daily living) [7]) and EQ-5D-3L (global health-
related quality of life [8]). Barthel scores range from 0 to 100,
with lower scores indicating more disability. EQ-5D-3L mea-
sures five dimensions (mobility, self-care, usual activities,
pain and anxiety/depression) and a global visual analogue
scale (VAS). Utility indices were derived from EQ-5D-3L
using Spanish national preference tables [9]. These range from
0 (death) or even negative values (worse than death) to 1 (full
health).
Statistical analyses
Barthel EQ-5D-3L is expressed as mean (standard deviation)
and as median (interquartile range) (Table 1). Change in utility
indices over time is plotted as a histogram (Fig. 1).
Results
Baseline outcome data was available for 997 patients, of
whom 856 (85.9%) completed 4 months of follow-up. Of
the 141 without follow-up data, 99 (9.9%) have died, and 42
(4.2%) were lost to follow-up. Detailed patient characteristics
have been previously reported [6]. Complete data on baseline
and 1- and 4-month Barthel and EQ-5D-3L were collected for
824/856 (96.3%) and 746/856 (90.2%) participants
respectively.
On average, overall health-related quality of life dropped
by 57% at the time of fracture, to then recover by 23% in the
first month and by a total 37% at 4-month post-admission.
Discussion
Our study demonstrates a significant fall in both EQ-5D and
the Barthel Index on sustaining a proximal femoral fracture,
and this falls only partial recovers at 4-week follow-up.
Barthel Index, assessing the ability to perform activities of
daily living fell from 79 to 44% immediately after sustaining
the fracture, with a recovery to 64% function 4-month post-
fracture. The impact on patient quality of life is even more
striking: participants started with 75% of full health which fell
to 0% of full health ‘like dead’ immediately after the fracture.
Partial recovery was again seen in the following 4 months,
increasing to a 60% full health.
Our results are similar to those found in similar cohort from
the UK [10], Norway [11] and Portugal [5]. In those, the
authors reported a gradual recovery up to 1 year in terms of
quality of life. These findings are also comparable to those
obtained from a smaller Spanish cohort [12]. As in our study,
improvement in quality of life seemed to be mirrored by func-
tional recovery in these previous studies. Other studies [13,
14] including the UK (WHiTE) study [15] have also shown
similar deterioration in functional status [16].
Our study has limitations. Our findings are only represen-
tative of the subjects who survived, as almost 10% of the study
participants died within 4 months, and it is possible that their
function and health status were worse at baseline and post-
fracture. In addition, recall bias is possible in the
Table 1 Change in health-related quality of life at the time of a femur fracture, and in the following 1 and 4 months of follow-up
Change in EQ-5D-3L utility at index admission Change in EQ-5D-3L from index
admission to 1 month
Change in EQ-5D-3L from 1 to 4 months
of follow-up
Mean (sd) − 0.57 (0.43) 0.23 (0.40) 0.37 (0.43)
Median (IQR) − 0.56 (− 0.90 to − 0.28) 0.16 (0.0 to 0.50) 0.34 (0.09 to 0.70)
*Positive values are equivalent to improvement/recovery; negative values mean worsening
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determination of pre-fracture (baseline) health status, as this
was recorded during the index hospital admission.
This analysis also has strengths. First, the prospective na-
ture of data collection and the fact that the information was
recorded by trained clinician/s and/or nurses give high validity
to our findings. Secondly, we have low attrition, with < 5%
loss to follow-up at 4-month post-fracture. Finally, our partic-
ipants were recruited from a representative sample of hospitals
around the country.
In conclusion, we report a sustained detriment of proximal
femoral fractures on the ability of a patient to perform activi-
ties of daily living and their health-related quality of life.
These data should be used to estimate the socioeconomic bur-
den of osteoporosis-related fractures and to inform the plan-
ning of care for these patients.
Funding information This work has been sponsored by an unrestricted
grant of AMGEN to the Hospital del Mar Institute of Medical
Investigation (IMIM).
Compliance with ethical standards
Conflicts of interest ADP is advisor or speaker for Amgen/UCB,
Roche, Gilead, EchoLight and Lilly. Institutional grant EchoLight and
Kiowa-Kirin and Shareholder Active Life Sci. DPA’s research group
has received unrestricted research grants from Servier, Amgen and
UCB; and speaker and consultancy fees fromAmgen and UCB. All other
authors report no conflict of interests.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Pedersen AB, Ehrenstein V, Szépligeti SK, Lunde A, Lagerros YT,
Westerlund A, Tell GS, Sørensen HT (2017) Thirty-five–year
trends in first-time hospitalization for hip fracture, 1-year mortality,
and the prognostic impact of comorbidity: a Danish nationwide
cohort study, 1980–2014. Epidemiology 28(6):898–905
2. Svedbom A, Hernlund E, Ivergård M, Compston J, Cooper C,
Stenmark J et al (2013) Osteoporosis in the European Union: a com-
pendium of country-specific reports. Arch Osteoporos 8(1–2):137
3. Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the
elderly: a world-wide projection. Osteoporos Int 2(6):285–289
4. Borgström F, Lekander I, Ivergård M, Ström O, Svedbom A,
Alekna V, Bianchi ML, Clark P, Curiel MD, Dimai HP, Jürisson
M, Kallikorm R, Lesnyak O, McCloskey E, Nassonov E, Sanders
KM, Silverman S, Tamulaitiene M, Thomas T, Tosteson ANA,
Jönsson B, Kanis JA (2013) The international costs and utilities
related to osteoporotic fractures study (ICUROS)—quality of life
during the first 4 months after fracture. Osteoporos Int 24(3):811–
823
5. Marques A, Lourenço Ó, da Silva J (2015) The burden of osteopo-
rotic hip fractures in Portugal: costs, health related quality of life
and mortality. Osteoporos Int 26(11):2623–2630
6. Prieto-Alhambra D, Reyes C, Sainz MS, González-Macías J,
Delgado LG, Bouzón CA, Gañan SM, Miedes DM, Vaquero-
Cervino E, Bardaji MFB, Herrando LE, Baztán FB, Ferrer BL,
Perez-Coto I, Bueno GA, Mora-Fernandez J, Doñate TE, Blasco
JMI, Aguado-Maestro I, Sáez-López P, Doménech MS, Climent-
Peris V, Rodríguez ÁD, Sardiñas HK, Gómez ÓT, Serra JT, Caeiro-
Rey JR, Cano IA, Carsi MB, Etxebarria-Foronda I, Hernández
JDA, Solis JR, Suau OT, Nogués X, Herrera A, Díez-Perez A
(2018) In-hospital care, complications, and 4-month mortality fol-
lowing a hip or proximal femur fracture: the Spanish registry of
osteoporotic femur fractures prospective cohort study. Arch
Osteoporos 13(1):96
7. Collin C,Wade D, Davies S, Horne V (1988) The Barthel ADL Index:
a reliability study. Disability and rehabilitation 10(2):61–63
8. EuroQol G (1990) EuroQol–a new facility for the measurement of
health-related quality of life. Health policy 16(3):199
Fig. 1 Histogram of EQ-5D-3L
utility indices at baseline (pre-fx),
at admission for a femur fracture
(fx date), and at 1 and 4 months of
follow-up
Arch Osteoporos (2019) 14: 56 Page 3 of 5 56
9. Badia X, Roset M, Herdman M, Kind P (2001) A comparison of
United Kingdom and Spanish general population time trade-off
values for EQ-5D health states. Med Decis Mak 21(1):7–16
10. Griffin X, Parsons N, Achten J, Fernandez M, Costa M (2015)
Recovery of health-related quality of life in a United Kingdom
hip fracture population: the Warwick hip trauma evaluation-a pro-
spective cohort study. Bone Joint J 97(3):372–382
11. Gjertsen J-E, Baste V, Fevang JM, Furnes O, Engesæter LB (2016)
Quality of life following hip fractures: results from the Norwegian
hip fracture register. BMC Musculoskelet Disord 17(1):265
12. Caeiro JR, Bartra A, Mesa-Ramos M, Etxebarría Í, Montejo J,
Carpintero P et al (2017) Burden of first osteoporotic hip fracture
in Spain: a prospective, 12-month, observational study. Calcif
Tissue Int 100(1):29–39
13. Ruths S, Baste V, Bakken MS, Engesæter LB, Lie SA, Haugland S
(2017) Municipal resources and patient outcomes through the first
year after a hip fracture. BMC Health Serv Res 17(1):144
14. Vergara I, Vrotsou K, Orive M, Gonzalez N, Garcia S, Quintana JM
(2014) Factors related to functional prognosis in elderly patients
after accidental hip fractures: a prospective cohort study. BMC
Geriatr 14(1):124
15. Costa ML, Griffin XL, Achten J, Metcalfe D, Judge A, Pinedo-
Villanueva R, Parsons N (2016) World hip trauma evaluation
(WHiTE): framework for embedded comprehensive cohort studies.
BMJ Open 6(10):e011679
16. Moerman S, Vochteloo AJ, Tuinebreijer WE, Maier AB,
Mathijssen NM, Nelissen RG (2016) Factors associated with the
course of health-related quality of life after a hip fracture. Arch
Orthop Trauma Surg 136(7):935–943
Publisher’s note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
Affiliations
D. Prieto-Alhambra1,2,3 & D. Moral-Cuesta4 & A. Palmer5 & I. Aguado-Maestro6 &M. F. Bravo Bardaji7 & F. Brañas8 &
G. Adrados Bueno9 & J. R. Caeiro-Rey10 & I. Andrés Cano11 &M. Barres-Carsi12 & L. Gracia Delgado13 &
M. Salomó-Domènech14 & I. Etxebarria-Foronda15 & B. Llado Ferrer16 & S. Mills17 & L. Ezquerra Herrando18 &D. Mifsut19 &
L. D. R. Evangelista20 & X. Nogués21 & I. Perez-Coto22 & J. Martínez-Iñiguez Blasco23 & C. Martín-Hernández24 &
H. Kessel25 & J. Teixidor Serra26 & J. Rodriguez Solis27 & O. Torregrosa Suau28 & E. Vaquero-Cervino29 &
C. Pablos Hernández30 & L. Rodríguez Mañas31 & A. Herrera32 & A. Díez-Perez33
1 GREMPAL (Grup de Recerca en Epidemiologia de les Malalties
Prevalents de l’Aparell Locomotor) Research Group, CIBERFES,
IDIAP Jordi Gol (Universitat Autònoma de Barcelona) and Instituto
de Salud Carlos III, Av Gran Via de les Corts Catalanes, 587, Atic,
08007 Barcelona, Spain
2 Musculoskeletal Pharmaco and Device Epidemiology - Centre for
Statistics in Medicine, Nuffield Department of Orthopaedics,
Rheumatology, andMusculoskeletal Sciences, University of Oxford,
Botnar Research Centre, Windmill Road, Oxford OX3 7LD, UK
3 Musculoskeletal Research Unit, IMIM-Parc Salut Mar, CIBERFES,
Universitat Autònoma de Barcelona, Doctor Aiguader 88,
08003 Barcelona, Spain
4 Geriatric Unit, Hospital Universitario La Paz, Paseo de la Castellana,
261, 28046 Madrid, Spain
5 Traumatology and Orthopaedics Unit, Nuffield Orthopedic Centre,
Windmill Rd, Headington, Oxford OX3 7HE, UK
6 Hospital Universitario Rio Hortega, Calle Dulzaina, 2,
47012 Valladolid, Spain
7 Hospital Regional Universitario de Malaga, Av. de Carlos Haya, s/n,
29010 Málaga, Spain
8 Geriatric Unit, Hospital Universitario Infanta Leonor, Gran Vía del
Este, 80, 28031 Madrid, Spain
9 Internal Medicine Unit, Hospital Infanta Cristina, Av. de Elvas, s/n,
06080 Badajoz, Spain
10 Traumatology and Orthopaedics Unit, Complejo Hospitalario
Universitario de Santiago de Compostela, Rúa da Choupana, s/n,
15706 Santiago de Compostela, A Coruña, Spain
11 Hospital Puerta del Mar, Av. Ana de Viya, 21, 11009 Cádiz, Spain
12 Hospital Universitari i Politècnic La Fe, Av de Fernando Abril
Martorell, 106, 46026 València, Spain
13 Hospital Universitario Reina Sofía de Cordoba, Av Menendez
Pidal, 14004 Córdoba, Spain
14 Corporación sanitaria Universitaria Parc Tauli, Parc Taulí, 1,
08208 Sabadell, Barcelona, Spain
15 Department of Orthopaedic, Alto Deba Hospital, Arrasate-
Mondragon, Gipuzkoa, Spain
16 Hospital Son Llàtzer, Carretera de Manacor, PQ 4 (Son Ferriol),
07198 Palma de Mallorca, Spain
17 Traumatology and Orthopaedics Unit, Hospital Universitario La
Paz, Paseo de la Castellana, 261, 28046 Madrid, Spain
18 F.E.A of the Traumatology and Orthopaedics Unit, Hospital Clínico
Universitario Lozano Blesa, Av. San Juan Bosco, 15,
50009 Zaragoza, Spain
19 Hospital Clínico de Valencia, Av de Blasco Ibáñez, 17,
46010 Valencia, Spain
20 Geriatric Unit, Hospital Universitario Severo Ochoa, Av. De
Orellana s/n, 28911 Leganés, Madrid, Spain
Arch Osteoporos (2019) 14: 5656 Page 4 of 5
21 Internal Medicine Department IMIM (Hospital del Mar Medical
Research), CIBER FES ISCIII, Universitat Autónoma de
Barcelona, Barcelona, Spain
22 Hospital Universitario San Agustín, Camino de Heros, 6,
33401 Avilés, Asturias, Spain
23 Hospital San Pedro, Calle Piqueras, 98, 26006 Logroño, La Rioja,
Spain
24 IIS Aragón (Instituto de Investigación Sanitaria de Aragón),
Hospital Universitario Miguel Servet, Paseo Isabel la Católica 1-3,
50009 Zaragoza, Spain
25 Geriatric Care Unit, Complejo Hospitalario Torrecárdenas, Calle
Hermandad de Donantes de Sangre, 04009 Almería, Spain
26 Hospital Universitari Vall de Hebron, Passeig de la Vall d’Hebron,
119-129, 08035 Barcelona, Spain
27 Geriatric Unit, Hospital Universitario de Guadalajara, Calle
Donante de Sangre, s/n, 19002 Guadalajara, Spain
28 Bone Metabolism Unit, Internal Medicine Unit, Hospital General
Universitari d’Elx, Carrer Almazara, 11, 03203 Elche, Alicante,
Spain
29 Complejo Hospitalario de Pontevedra, Av Montecelo, 0, 36164,
Casas Novas, Pontevedra, Spain
30 Geriatric Unit, Hospital de Salamanca, Paseo de San Vicente, 139,
37007 Salamanca, Spain
31 Geriatric Unit, Hospital Universitario de Getafe, Carr. De Madrid -
Toledo, Km 12,500, 28905 Getafe, Madrid, Spain
32 Department of Surgery, Aragón Health Research Institute,
University of Zaragoza, Zaragoza, Spain
33 Musculoskeletal Research Unit, IMIM-Parc Salut Mar, CIBERFES,
Universitat Autònoma de Barcelona, Doctor Aiguader 88,
08003 Barcelona, Spain
Arch Osteoporos (2019) 14: 56 Page 5 of 5 56
